Possible Benefits of Medical Cannabis

Medical cannabis isn't a cure-all, and any honest discussion has to start there. But for several specific conditions, peer-reviewed studies and federal health agencies acknowledge meaningful potential benefits — often when other treatments have fallen short. This page summarizes what that body of evidence currently looks like, written for South Carolina patients trying to decide whether a medical evaluation is worth pursuing.

What the research shows

In 2017 the National Academies of Sciences, Engineering, and Medicine published a comprehensive review of more than 10,000 studies on the health effects of cannabis. They concluded there is conclusive or substantial evidence that cannabis or cannabinoids are effective for three uses:

• Treatment of chronic pain in adults.
• Reducing chemotherapy-induced nausea and vomiting (with oral cannabinoids).
• Improving patient-reported multiple sclerosis spasticity symptoms.

For several other conditions the evidence is described as moderate or limited but still meaningful — and research has continued to evolve in the years since.

Conditions with the strongest evidence

Chronic pain

Chronic pain is the single most common reason patients pursue medical cannabis nationally. Multiple systematic reviews — including ones published in JAMA and the Annals of Internal Medicine — have found that cannabinoids can produce a modest but real reduction in pain scores, particularly for neuropathic (nerve) pain. For some patients this means lower doses of opioids; for others it means better sleep and function rather than complete pain elimination.

Chemotherapy-induced nausea and appetite loss

The FDA has approved two cannabinoid medications (dronabinol and nabilone) specifically for chemotherapy-related nausea and vomiting that hasn't responded to standard antiemetics. The National Cancer Institute recognizes that cannabis can help with nausea, appetite stimulation, and pain in cancer patients.

Multiple sclerosis spasticity

Patient-reported reductions in muscle spasticity are among the most consistent findings in the cannabis literature. Nabiximols (a plant-derived oromucosal spray) is approved in many countries specifically for this use.

Certain treatment-resistant seizure disorders

The FDA has approved Epidiolex — a purified plant-derived CBD product — for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. Clinical trials demonstrated meaningful seizure reductions for patients who hadn't responded to other anticonvulsants.

PTSD symptoms

Evidence here is more mixed. Some observational studies and smaller controlled trials suggest that certain cannabis preparations may help with sleep disturbance, nightmares, and hyperarousal in PTSD. Larger, higher-quality trials are still needed. Many veterans report subjective benefit; the research community is working to catch up.

Sleep disturbance tied to chronic illness

Cannabis is widely used for sleep, and short-term studies show improvements in sleep onset and continuity for patients with chronic pain, PTSD, and certain neurological conditions. Long-term effects on sleep architecture are less well-understood.

The limits of the current evidence

Honest medicine requires honest limits. Cannabis research has been constrained for decades by federal scheduling, which restricted who could study it and what plant material could be studied. As a result:

• Many studies are small, short-term, or use cannabis preparations that differ significantly from what's available in state programs.
• Effect sizes are often modest. Cannabis may help — but it rarely produces the dramatic effects pharmaceutical advertising sometimes implies.
• We don't yet have great long-term safety data for daily medical use across decades.
• Individual response varies enormously. What helps one patient may do nothing for another, or even make them feel worse.

CBD vs. THC — they're different tools

Cannabis contains dozens of active compounds, but the two most studied are CBD (cannabidiol) and THC (tetrahydrocannabinol). They behave very differently:

• CBD is non-intoxicating. It's the active compound in Epidiolex and is most often associated with anti-seizure, anti-inflammatory, and anxiolytic effects.
• THC is intoxicating. It's responsible for the "high," and it's also the compound most strongly linked to pain relief, appetite stimulation, and anti-nausea effects.
• Many medical preparations combine the two in specific ratios — and the ratio matters significantly for both effect and side-effect profile.

How to talk to your provider

Bring three things to your evaluation:

• A clear description of your symptoms, what you've already tried, and what hasn't worked.
• A current and complete medication list — including supplements — so your physician can think carefully about interactions.
• Honest goals. "I want to sleep through the night" or "I want to walk without limping" gives your provider something concrete to work toward; "I want to feel better" is harder to act on.

The bottom line

For chronic pain, certain seizure disorders, chemotherapy-related symptoms, and MS spasticity, the evidence supporting medical cannabis is real and growing. For other conditions it's promising but less mature. For some, it's not the right tool at all.

The only way to know whether medical cannabis makes sense for you is a thoughtful conversation with a licensed physician who has reviewed your records. That's exactly what Medical Marijuana Doctors of South Carolina is being built to make easier — when and only when state law permits.